Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Visine Dry Eye Relief is an over-the-counter ophthalmic lubricant developed by Kenvue (formerly a division of Johnson & Johnson). The product's sole active ingredient is polyethylene glycol 400 at a 1% concentration. It functions as a humectant and lubricant to provide temporary relief from burning, irritation, and discomfort associated with dry eyes or exposure to environmental factors such as wind and sun. The formulation is designed to mimic natural tears, providing mechanical lubrication and moisture to the ocular surface without targeting a specific biological receptor. It is typically administered as eye drops up to four times daily.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Visine Dry Eye Relief.